Cellectar Biosciences Jumps 200% After Geting Patent Identification Numbers For Cancer Targeting Drug Vehicles

By: via Benzinga
Cellectar Biosciences, Inc. (NASDAQ: CLRB), an oncology-focused biotechnology company, revealed Friday that it got patent ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.